Completed Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL NCT04030195 Conditions B-cell Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, Chronic Disease, +25 more Locations City of Hope — Duarte, California, United States Stanford University — Stanford, California, United States Columbia University — New York, United States Cleveland Clinic — Cleveland, Ohio, United States View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Belimumab in Patients with Chronic Lymphocytic Leukemia NCT05069051 Conditions Chronic Lymphoid Leukemia in Relapse Locations University Hospital Tuebingen, CCU Translational Immunology — Tübingen, Baden-Wurttemberg, Germany View Trial Details
